VICTORY CAPITAL MANAGEMENT INC

Position in ABSI — Absci Corp

CIK 1040188 San Antonio, TX

Position in ABSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$452,997

-$78,481 QoQ

Shares Held

150,999

-0.8% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,020,556,215 across 156 Biotechnology names. ABSI ranks #96 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$452,997	150,999	-0.8%	Shares	Sole	2026-05-15
2025-12-31	$531,478	152,286	+0.4%	Shares	Sole	2026-02-13
2025-09-30	$461,119	151,684	+0.9%	Shares	Sole	2025-11-12
2025-06-30	$386,404	150,352	+3.0%	Shares	Sole	2025-08-13
2025-03-31	$366,342	145,953	-0.9%	Shares	Sole	2025-05-02
2024-12-31	$385,802	147,253	-2.2%	Shares	Sole	2025-02-06
2024-09-30	$575,146	150,562	+5.9%	Shares	Sole	2024-11-05
2024-06-30	$437,895	142,174	-23.5%	Shares	Sole	2024-08-05
2024-03-31	$1,055,616	185,848	+208.2%	Shares	Sole	2024-05-03
2022-06-30	$200,229	60,310	0.0%	Shares	Sole	2022-08-01
2022-03-31	$508,413	60,310	-4.1%	Shares	Sole	2022-05-04
2021-12-31	$515,616	62,880	-5.0%	Shares	Sole	2022-02-07
2021-09-30	$769,557	66,170	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.